UGT2A3 and colorectal carcinoma: Survival analysis revealed that elevated expression levels of CDC14A (p = 0.011, HR = 0.69), PDK2 (p = 0.018, HR = 0.69), and UGT2A3 (p = 0.046, HR = 0.72) were significantly associated with improved overall survival in CRC patients.